Viracta Therapeutics Inc (VIRX) Insider Trading
- $70,006.06
- $402,962.72
- Feb. 27, 2024
- Daniel R Chevallard
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 27, 2024 | CFO | 3,405 | $0.73 | Sell | $2,485.65 | |
| Nov. 30, 2023 | CEO | 52,094 | $0.49 | Buy | $25,526.06 | |
| Nov. 28, 2023 | CFO | 3,720 | $0.50 | Sell | $1,860.00 | |
| Aug. 28, 2023 | CFO | 3,512 | $1.45 | Sell | $5,092.40 | |
| May 25, 2023 | CFO | 3,635 | $1.42 | Sell | $5,161.70 | |
| Feb. 27, 2023 | Insider | 2,156 | $1.68 | Sell | $3,622.08 | |
| Feb. 27, 2023 | CFO | 3,599 | $1.68 | Sell | $6,046.32 | |
| Nov. 28, 2022 | Insider | 2,116 | $2.72 | Sell | $5,755.52 | |
| Nov. 28, 2022 | CFO | 3,532 | $2.72 | Sell | $9,607.04 | |
| Aug. 26, 2022 | Insider | 2,190 | $4.01 | Sell | $8,781.90 | |
| Aug. 26, 2022 | CFO | 3,655 | $4.02 | Sell | $14,693.10 | |
| Aug. 26, 2022 | CEO | 13,379 | $4.01 | Sell | $53,649.79 | |
| May 26, 2022 | CFO | 3,596 | $1.90 | Sell | $6,832.40 | |
| May 26, 2022 | CEO | 13,162 | $1.90 | Sell | $25,007.80 | |
| May 26, 2022 | Insider | 2,154 | $1.90 | Sell | $4,092.60 | |
| Feb. 28, 2022 | Insider | 2,395 | $2.78 | Sell | $6,658.10 | |
| Feb. 28, 2022 | CFO | 3,998 | $2.78 | Sell | $11,114.44 | |
| Feb. 28, 2022 | CEO | 14,635 | $2.78 | Sell | $40,685.30 | |
| Nov. 29, 2021 | CEO | 15,833 | $4.82 | Sell | $76,315.06 | |
| Nov. 29, 2021 | Insider | 2,591 | $4.82 | Sell | $12,488.62 | |
| Nov. 29, 2021 | CFO | 4,325 | $4.82 | Sell | $20,846.50 | |
| Nov. 26, 2021 | Insider | 1,950 | $4.80 | Sell | $9,360.00 | |
| Nov. 26, 2021 | CFO | 3,254 | $4.80 | Sell | $15,619.20 | |
| Nov. 26, 2021 | CEO | 11,914 | $4.80 | Sell | $57,187.20 | |
| Nov. 15, 2021 | CEO | 8,000 | $5.56 | Buy | $44,480.00 |
Insiders are both buying and selling Viracta Therapeutics Inc stock.
The insider traders at Viracta Therapeutics Inc are: Daniel R Chevallard, Lisa Rojkjaer, Ivor Royston, and Mark Rothera
The most active insider trader at Viracta Therapeutics Inc is Daniel R Chevallard with 11 trades.
Ivor Royston has sold the most Viracta Therapeutics Inc stock with a total value of $306,494.94.
Ivor Royston has bought the most Viracta Therapeutics Inc stock with a total value of $88,960.00.
The most recent insider trade for Viracta Therapeutics Inc was on Feb. 27, 2024.
The single biggest insider buy for Viracta Therapeutics Inc was from Ivor Royston with a total value of $44,480.00 on Nov. 15, 2021.
The single biggest insider sell for Viracta Therapeutics Inc was from Ivor Royston with a total value of $76,315.06 on Nov. 29, 2021.